On August 1, 2018 Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, reported its participation in the following upcoming investor conferences (Press release, Blueprint Medicines, AUG 1, 2018, View Source;p=RssLanding&cat=news&id=2361416 [SID1234528389]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

38th Annual Canaccord Genuity Growth Conference in Boston, MA on Wednesday, August 8, 2018 at 3:00 p.m. E.T.

2018 Wedbush PacGrow Healthcare Conference in New York, NY on Wednesday, August 15, 2018 at 9:10 am. E.T.

A live webcast of each presentation will be available by visiting the Investors section of Blueprint Medicines’ website at View Source A replay of the webcast will be archived on Blueprint Medicines’ website for 30 days following each presentation.